Society of Cannabis Clinicians

Educating Healthcare Professionals
About the Medical Use of Cannabis

Who We Are

The SCC is a nonprofit educational and scientific society of healthcare professionals and allies dedicated to advancing research and disseminating knowledge about medical cannabis.

Physician Locator Map

Are you looking for a cannabis-knowledgable physician? Are you a healthcare provider wanting to highlight your practice? Our Locator Map guides prospective patients to clinician members.

Research Library

The SCC supports the practice of evidence-based cannabinoid medicine. All articles in the collection have been vetted to ensure only rigorous, unbiased, and non-commercialized studies are included.

COURSE OFFERINGS

Latest News

,

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Cannabidiol is showing promising results for the treatment of COVID-19, due to its capa- bility of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19.

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users.
,

Cannabinoids as Emergent Therapy Against COVID-19

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2(SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massiveimpact. Despite a fast development and implementation of vaccination strategies, and the scouting of severalpharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids repre-sent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. Thismini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far iden-tified for the treatment and prevention of COVID-19, finally considering key aspects related to their technologicaland clinical implementation.
,

Synergy with Cannabis and Other Herbs: Thinking Beyond Plant Constituents

Explore the different types of plant synergy, herbs that may combine well with cannabis, and the healing properties of botanicals that science will never be able to fully explain.
,

Tic Disorder Management with Cannabis: A Family’s Tale Meets the Science

Dr. Genevieve Newton describes the state of the research on cannabis in the treatment of tic disorders and what her young son's experience with cannabis has been like.
,

Cannabis as a Multifaceted Treatment Approach to Alzheimer’s Disease

Current treatments cannot stop or reverse the progression of the Alzhiemer’s disease. Learn how cannabis medicine may be a valid treatment option to alleviate the multitude of complex symptoms associated with this condition.
21 years

As an organization

38 States

Members practice in

24 Countries

Our members represent

737 Articles

in the Research Library

Membership & Online Learning

Membership information

Diversity within the SCC is critical to our success and ability to educate each other. Healthcare professionals and allies are welcome to join, including (but not limited to): physicians, nurses, pharmacists, caregivers, veterinarians, herbalists, physical therapists, researchers, and patients.

Video Library

View our robust collection of presentations by leading international experts sharing cannabis science and medical applications. There are various free options available to everyone. Full videos of quarterly meetings and other exclusive content is viewable in the Members Portal.

O’Shaughnessy’s Journal

SCC Founder Tod Mikuriya, MD was a physician, researcher, and creator of a new “Cannabis Clinician” specialty. Tod envisioned a journal where clinicians monitoring patients’ cannabis use could share observations. O’Shaughnessy’s continues to this day.

Global Impact

Affiliates & Allies